欢迎来到《四川大学学报（医学版）》
高级检索
杨景瑞, 陈梦闽, 邓侠兴, 等. 机器人手术系统联合血管切除重建行胰十二指肠切除术的17例疗效评价（附手术视频）[J]. 四川大学学报（医学版）, 2020, 51(4): 462-466. DOI: 10.12182/20200760202
引用本文: 杨景瑞, 陈梦闽, 邓侠兴, 等. 机器人手术系统联合血管切除重建行胰十二指肠切除术的17例疗效评价（附手术视频）[J]. 四川大学学报（医学版）, 2020, 51(4): 462-466. DOI: 10.12182/20200760202
shu
YANG Jing-rui, CHEN Meng-min, DENG Xia-xing, et al. The Efficacy of 17 Cases of Pancreaticoduodenectomy Combined with Vascular Resection and Reconstruction by Using Robotic Operation System (with Video)[J]. Journal of Sichuan University (Medical Sciences), 2020, 51(4): 462-466. DOI: 10.12182/20200760202
Citation: YANG Jing-rui, CHEN Meng-min, DENG Xia-xing, et al. The Efficacy of 17 Cases of Pancreaticoduodenectomy Combined with Vascular Resection and Reconstruction by Using Robotic Operation System (with Video)[J]. Journal of Sichuan University (Medical Sciences), 2020, 51(4): 462-466. DOI: 10.12182/20200760202
shu

机器人手术系统联合血管切除重建行胰十二指肠切除术的17例疗效评价（附手术视频）

The Efficacy of 17 Cases of Pancreaticoduodenectomy Combined with Vascular Resection and Reconstruction by Using Robotic Operation System (with Video)

    摘要
  • 摘要:
      目的  探讨机器人手术系统下联合血管切除重建行胰十二指肠切除术治疗进展期胰腺癌的临床疗效。
      方法  回顾性分析自2011年8月−2018年9月上海交通大学医学院附属瑞金医院完成的17例机器人手术系统下联合血管切除重建（操作见视频1）行胰十二指肠切除术的局部进展期的胰腺癌患者的临床资料。
      结果  17例患者中4例胰腺癌患者由于肿瘤侵犯严重、胰腺质地软中转开腹，13例患者手术顺利完成。16例（94%）患者手术达到R0切除。14例联合静脉重建，3例联合动脉重建。平均手术时间（401±170） min，平均术中出血（647±345） mL，术后平均住院天数（20±8） d，无围手术期死亡。术后病理及随访结果：1例为胰腺导管内乳头状黏液肿瘤，1例为胰腺神经内分泌肿瘤（G1级），目前情况良好，8例胰腺导管腺癌及1例胰腺神经内分泌癌患者于随访期间因肿瘤复发转移死亡，中位（最小值～最大值）生存期12（8～26）个月。5例胰腺导管腺癌及1例恶性胰腺导管内乳头状黏液肿瘤患者目前继续随访中，其中1例已存活了38个月（截止至2019年7月）。
      结论  机器人手术系统下联合血管切除重建行胰十二指肠切除术难度较大，但安全可行，局部进展期的胰腺癌患者经谨慎评估患者病情和医院手术能力后可以采用。

     

    Abstract:
      Objective  To explore the clinical efficacy of pancreaticoduodenectomy (PD) combined with vascular resection and reconstruction under robotic surgery system in the treatment of borderline resectable pancreatic cancer.
      Methods   The clinical data of 17 patients with borderline resectable pancreatic cancer who underwent PD combined with vascular resection and reconstruction (see the Video 1 in Supplemental Contents, http://ykxb.scu.edu.cn/article/doi/10.12182/20200760202) under robotic surgery system between August 2011 and September 2018 was analyzed retrospectively.
      Results  There were 4 cases required conversion because of serious tumor invasion and soft pancreas texture, the other 13 cases were successfully completed. 16 cases (94%) achieved margin-negative resection (R0 resection), 14 cases combined with vein resection, and 3 cases combined with arterial resection. The mean operation time was (401±170) min, the mean blood loss was (647±345) mL, the mean postoperative length of hospital stay was (20±8) d. There was no perioperative death. Postoperative pathology findings and follow-up outcomes were as follows: 1 patient was diagnosed as intraductal papillary mucinous neoplasm (IPMN) and 1 patient was diagnosed as pancreatic neuroendocrine tumors (PNET) (Grade 1), 8 patients with pancreatic ductal adenocarcinoma (PDAC). 1 patient with pancreatic neuroendocrine carcinoma (PNEC) died because of tumor recurrence and metastasis during the follow-up period, the median (Min-Max) survival time was 12 (8-26) months. 5 patients with PDAC and 1 patient with malignant IPMN were currently in the follow-up period.
      Conclusion  It is safe and feasible to perform RPD with vascular resection and reconstruction. The patient's condition should be fully evaluated before surgery to select the most appropriate treatment.

     

    • HTML全文
    • 参考文献(15)
    • 相关文章
    • 施引文献
  • 资源附件(1)
© 2020 《四川大学学报（医学版）》编辑部　版权所有 cc

开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议（CC BY-NC 4.0），允许第三方对本刊发表的论文自由共享（即在任何媒介以任何形式复制、发行原文）、演绎（即修改、转换或以原文为基础进行创作），必须给出适当的署名，提供指向本文许可协议的链接，同时标明是否对原文作了修改；不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问 https://creativecommons.org/licenses/by-nc/4.0

/

返回文章
返回